United States · 
How much has ImmunityBio raised?
ImmunityBio has raised $80M across 1 round since 2025.
United States · Funded startup
Who invested in ImmunityBio
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow ImmunityBio and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$80Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $80MJul 2025
- Investors
- 0
The rounds
- Jul 2025Round$80M
No investor was named in the report.
Source recorded
Founders and team
From ImmunityBio's own website and the SEC filings it signed: 9 on the team.
- Rich AdcockPresident & Chief Executive Officer
- Elizabeth GabitzschSenior Vice President, Product Development & Vaccine Programs
- Emily ArisonSenior Vice President of Human Resources
- Matthew HilmanVice President US Commercial – Urologic Oncology
- Sarah SingletonChief Communications Officer & Head of Patient Advocacy
- Regan LauerChief Accounting Officer
- David SachsChief Financial Officer
- Dr. Patrick Soon-ShiongExecutive Chairman and Global Chief
- Richard AdcockExecutive Officer, Directori
On the board, as filediBarry SimonCheryl CohenChristobel SeleckyJohn BrennanLinda MaxwellMichael BlaszykWesley Clark
Also claim to have backed them
This firm lists ImmunityBio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ImmunityBio
When did ImmunityBio last raise?
ImmunityBio's most recent round was an Undisclosed round of $80M in Jul 2025.
What was ImmunityBio's biggest round?
Its most recent round, $80M in Jul 2025, is also its largest on record.
What stage is ImmunityBio at?
ImmunityBio's latest named round is an Undisclosed round, in Jul 2025.
Where is ImmunityBio based?
ImmunityBio is based in the United States.
Companies like ImmunityBio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.